<DOC>
	<DOCNO>NCT02002988</DOCNO>
	<brief_summary>The aim prospective non-randomized study ass efficacy safety endomyocardial botulinum toxin injection projection main ganglionated plexus leave atrium prevent drug-resistant paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>Botulinum Toxin Injection Prevent Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>drugresistant PAF Previous heart surgery AF ablation procedure Emergency CABG Unstable angina heart failure Persistent AF , AF time screen ( plan Maze procedure pulmonary vein isolation ) Use I III antiarrhythmic drug within 5 elimination halflives drug ( within 2 month amiodarone ) Requiring concomitant valve surgery Left ventricle ejection fraction &lt; 35 % Left atrial diameter &gt; 55 mm Unwillingness participate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>